Simplex Trading
TRVI icon

Simplex Trading’s Trevi Therapeutics TRVI Stock Holding History

Simplex Trading’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Sell
20,277
-26,857
-57% -$301K ﹤0.01% 4069
2025
Q4 		$590K Sell
47,134
-16,015
-25% -$185K ﹤0.01% 3139
2025
Q3 		$577K Buy
+63,149
New +$474K ﹤0.01% 3644
2025
Q1 		– Sell
-24,913
Closed -$119K – 9713
2024
Q4 		$102K Buy
24,913
+15,272
+158% +$48.9K ﹤0.01% 5162
2024
Q3 		$32K Buy
+9,641
New +$28.7K ﹤0.01% 6308
2023
Q2 		– Sell
-10
Closed – – 9962
2023
Q1 		$0 Hold
10
– – ﹤0.01% 10151
2022
Q4 		$0 Buy
+10
New +$20 ﹤0.01% 10460

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return